UCLA Health researchers showcase advances in radiation oncology at ASTRO
· News-MedicalUCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation therapies will present data on the latest radiation oncology research and clinical trial results at the 66th annual American Society for Radiation Oncology (ASTRO) meeting in Washington D.C., Sept. 29 to Oct. 2.
Highlights of noteworthy presentations at ASTRO that are led by UCLA investigators include:
Abstract 1071: MicroRNA-Based Germline Biomarkers of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
Weidhaas will present the findings during Session: QP 13-GI 4: GI Cancers: From top to bottom on Tuesday, Oct. 1 at 4pm EST in room 152.
Abstract 317: Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: 2-Year Outcomes from the MIRAGE Randomized Clinical Trial
Abstract 122: Symptom Monitoring with Patient-Reported Outcomes during Definitive Radiation Treatment
Raldow will report the findings in Session: SS 04 - PRO/QoL/Survivorship 1: New frontiers in patient reported outcomes and survivorship on Sunday, Sept. 19 at 3:45pm EST in room 204.
Source: